http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-120194-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d18f3e2b23d066a332bdbe7a2ab66e86 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 |
| filingDate | 2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-120194-U |
| titleOfInvention | METHOD OF PREVENTION OF MEDICAMENTOSE NEFTROXICITY IN PATIENTS WITH LUNG TUBERCULOSIS IN THE POST-OPERATION PERIOD |
| abstract | A method of preventing drug nephrotoxicity in patients with pulmonary tuberculosis in the postoperative period involves the abolition of potential nephrotoxic drugs and adequate control of blood pressure and water balance. Assign intravenously to a 500 mg dose of corvitin dissolved in 100 ml of 0.9% NaCl solution, administered 30 min once daily, and reamberin in a pharmacopoeia tolerable dose and administration regimen, which is used until renal marker normalization and for 2 days to stabilize achieved effect. |
| priorityDate | 2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.